Angioplasty Balloons Market Report 2025

This Angioplasty Balloons market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The angioplasty balloons market size has grown strongly in recent years. It will grow from $2.73 billion in 2024 to $2.87 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to increasing clinical trials, decreasing regulatory hurdles, rising physician training programs, growing reimbursement coverage, and expanding patient awareness and education.

The angioplasty balloons market size is expected to see steady growth in the next few years. It will grow to $3.47 billion in 2029 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to aging population, rising prevalence of cardiovascular diseases, expanding healthcare infrastructure in emerging markets, increasing adoption of minimally invasive procedures, and growing demand for interventional cardiology. Major trends in the forecast period include personalized treatment approaches, integration of advanced imaging technologies, shift towards outpatient procedures, expansion of telemedicine for post-operative care, and emphasis on cost-effective healthcare solutions.

The rising incidence of cardiovascular diseases is expected to drive the growth of the angioplasty balloons market in the coming years. Cardiovascular diseases encompass a range of conditions that affect the heart and blood vessels, often leading to severe complications such as heart attacks or strokes. The prevalence of these diseases is increasing due to factors such as sedentary lifestyles, poor dietary habits, rising obesity rates, and aging populations. Angioplasty balloons are used in the treatment of cardiovascular diseases to widen narrowed or blocked blood vessels, restoring proper blood flow and reducing the risk of complications. For example, in September 2024, data published by the Minnesota Department of Health, a US-based state health agency, revealed that approximately 30% of adults in Minnesota reported having high blood pressure in 2023, affecting nearly 1.4 million people. In 2022, hypertensive diseases were the underlying or contributing cause of death for 14,225 residents, accounting for nearly 28% of all deaths in the state. Therefore, the increasing incidence of cardiovascular diseases is driving the growth of the angioplasty balloons market.

Major companies in the angioplasty balloons market are concentrating on developing innovative products, such as advanced medical balloon forming systems, to improve precision in manufacturing high-pressure balloons for critical cardiac procedures. The Advanced Medical Balloon Forming System is designed for the precise production of compliant medical balloons used in catheter systems. For example, in June 2024, Interface Catheter Solutions, a US-based innovator in catheter technology, introduced the BFM-5510 High Force Balloon Forming Machine. This advanced benchtop system is specifically engineered for producing low- and non-compliant polymer balloons used in angioplasty, stent placement, and other vital cardiac procedures. Building on the BFM-3310 platform, the BFM-5510 HF utilizes beryllium copper molds to precisely shape extruded balloon tubing, ensuring stringent quality and tight tolerances across various sizes and shapes. This machine enhances production capabilities to meet the demands of larger, thicker, and more complex medical balloon manufacturing.

In December 2022, Johnson & Johnson, a US-based healthcare products company, completed the acquisition of Abiomed Inc. for $16.6 billion. This strategic move is geared towards expanding Johnson & Johnson's medtech portfolio, advancing heart recovery solutions, accelerating growth, and enhancing patient care by leveraging Abiomed's innovative cardiovascular technologies and expertise. Abiomed Inc., a US-based provider, manufactures the SupraCor Balloon Catheter, utilized in angioplasty procedures, thus complementing Johnson & Johnson's commitment to addressing the evolving needs of cardiovascular patients.

Major companies operating in the angioplasty balloons market are Johnson & Johnsona, Abbott Laboratories, Medtronic Plc, Becton Dickinson, Koninklijke Philips N.V, Boston Scientific Corporation, B. Braun SE, Terumo Corporation, Cook Medical, Biotronik SE, Merit Medical Systems Inc, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, AngioDynamics, Cordis, SurModics, iVascular, Hexacath, Balton Sp, Cardionovum, QualiMed Innovative Medizinprodukte GmbH, Acrostak, Panmed US Inc., Translumina GmbH, Concept Medical Inc.

North America was the largest region in the angioplasty balloons market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angioplasty balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the angioplasty balloons market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Angioplasty balloons are medical tools utilized to alleviate narrowed or obstructed blood vessels within the body. Commonly employed in addressing conditions such as coronary artery disease and peripheral artery disease, these balloons function by expanding within the artery, exerting pressure on plaque deposits to restore blood flow.

Angioplasty balloons come in several types, including normal balloons, scoring balloons, drug-eluting balloons, and cutting balloons. Normal balloons represent the fundamental angioplasty devices lacking specialized features, intended for the dilation of narrowed or blocked blood vessels through inflation. These balloons are fabricated from various materials such as non-compliant and semi-compliant substances. They find application across a spectrum of procedures, including coronary and peripheral angioplasty, and are utilized by diverse end-users including hospitals, specialty clinics, catheterization laboratories, ambulatory surgical centers, among others.

The angioplasty balloons market research report is one of a series of new reports that provides angioplasty balloons market statistics, including angioplasty balloons industry global market size, regional shares, competitors with an angioplasty balloons market share, detailed angioplasty balloons market segments, market trends and opportunities, and any further data you may need to thrive in the angioplasty balloons industry. This angioplasty balloons market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The angioplasty balloons market consists of sales of rapid exchange balloons, drug-eluting stent balloons, and microcatheter-compatible balloons. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.